Adeshwar Meditex Limited (BOM:543309)

Market Cap	303.06M -23.5%
Revenue (ttm)	728.75M -2.2%
Net Income	18.93M -13.4%
EPS	1.31 -13.9%
Shares Out	14.43M
PE Ratio	16.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Average Volume	20,100
Open	21.00
Previous Close	18.75
Day's Range	21.00 - 21.00
52-Week Range	13.30 - 25.00
Beta	0.85
RSI	59.29
Earnings Date	Feb 11, 2026

About Adeshwar Meditex

Adeshwar Meditex Limited manufactures and exports sterile surgical wound dressing products and medical disposables in India and internationally. It offers sterile wound dressings under PETRONET, PARAHEAL, BACTIGAUZE PLUS, NITROHEAL, PIVIDINE POVITULLE, POVIZOLE, FRAMITULLE, FUSITULLE, CALGINATE-AG SILVINET, HYDRASOOTHE, POLYBANE, and POLYBANE-N brands; combine dressings, including eye pads under the COMBIDRESS and COMBIPAD brands; and gauze dressing and cotton products, such as cotton stockinette, kneecaps, cast paddings under the ORTHOWRAP bra...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1951
• Employees: 26
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543309

Financial Performance

In fiscal year 2025, Adeshwar Meditex's revenue was 837.13 million, an increase of 4.84% compared to the previous year's 798.50 million. Earnings were 20.66 million, an increase of 2.87%.